{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:10:51Z","timestamp":1777551051703,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012399","name":"BARDA","doi-asserted-by":"publisher","award":["TTI-LOA17-SII-1"],"award-info":[{"award-number":["TTI-LOA17-SII-1"]}],"id":[{"id":"10.13039\/100012399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012399","name":"BARDA","doi-asserted-by":"publisher","award":["IDSEP130015-01"],"award-info":[{"award-number":["IDSEP130015-01"]}],"id":[{"id":"10.13039\/100012399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012399","name":"BARDA","doi-asserted-by":"publisher","award":["IDSEP130018-01-06"],"award-info":[{"award-number":["IDSEP130018-01-06"]}],"id":[{"id":"10.13039\/100012399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005624","name":"PATH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012737","name":"Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012737","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.vaccine.2018.10.002","type":"journal-article","created":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T11:36:40Z","timestamp":1539344200000},"page":"6944-6952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Immunogenicity and efficacy of the monovalent, trivalent and quadrivalent intranasal live attenuated influenza vaccines containing different pdmH1N1 strains"],"prefix":"10.1016","volume":"36","author":[{"given":"Leena R.","family":"Yeolekar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parikshit","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilesh B.","family":"Ingle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koert J.","family":"Stittelaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon de","family":"Waal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco Berlanda","family":"Scorza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kutub","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeev M.","family":"Dhere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2018.10.002_b0005","first-page":"16","article-title":"Influenza: the once and future pandemic","volume":"125","author":"Taubenberger","year":"2010","journal-title":"Public Health Rep"},{"key":"10.1016\/j.vaccine.2018.10.002_b0010","doi-asserted-by":"crossref","unstructured":"Live attenuated influenza vaccine for children. Drug Ther Bull 2017;55(10):14\u2013117.","DOI":"10.1136\/dtb.2017.10.0538"},{"issue":"3","key":"10.1016\/j.vaccine.2018.10.002_b0015","doi-asserted-by":"crossref","first-page":"ofx111","DOI":"10.1093\/ofid\/ofx111","article-title":"Live-attenuated influenza vaccine effectiveness in children from 2009 to 2015\u20132016: a systematic review and meta-analysis","volume":"4","author":"Caspard","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2018.10.002_b0020","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4161\/hv.27490","article-title":"Effectiveness of an Indian-made attenuated influenza A(H1N1)pdm 2009 vaccine- a case control study","volume":"10","author":"Kulkarni","year":"2014","journal-title":"Human Vacc Immunotherap"},{"key":"10.1016\/j.vaccine.2018.10.002_b0025","doi-asserted-by":"crossref","first-page":"e946","DOI":"10.1016\/S2214-109X(16)30200-5","article-title":"Efficacy of a Russian-backbone live attenuated influenza vaccine among young children in Bangladesh: a randomised, double-blind, placebo-controlled trial","volume":"4","author":"Brooks","year":"2016","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2018.10.002_b0030","doi-asserted-by":"crossref","first-page":"e955","DOI":"10.1016\/S2214-109X(16)30201-7","article-title":"Efficacy of a Russian-backbone live attenuated influenza vaccine among children in Senegal: a randomised, double-blind, placebo-controlled trial","volume":"4","author":"Victor","year":"2016","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2018.10.002_b0035","unstructured":"Bright H, Mallory R. Update on status of investigation of reduced LAIV effectiveness. In: ACIP Meeting; 2017. Available at: <https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2017-02\/influenza-06-bright-and-mallory.pdf>."},{"issue":"38","key":"10.1016\/j.vaccine.2018.10.002_b0040","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.38.30346","article-title":"Effectiveness of the live attenuated and the inactivated influenza vaccine in two-year-olds\u2013a nationwide cohort study Finland, influenza season 2015\/16","volume":"21","author":"Nohynek","year":"2016","journal-title":"Euro Surveill"},{"issue":"42","key":"10.1016\/j.vaccine.2018.10.002_b0045","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1016\/j.vaccine.2016.08.079","article-title":"Association of vaccine handling conditions with effectiveness of live attenuated influenza vaccine against H1N1pdm09 viruses in the United States","volume":"34","author":"Caspard","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.10.002_b0050","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.1016\/j.vaccine.2011.09.049","article-title":"Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets","volume":"29","author":"Stittelaar","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.10.002_b0055","first-page":"493","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"issue":"4","key":"10.1016\/j.vaccine.2018.10.002_b0060","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF01863914","article-title":"Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche","volume":"162","author":"K\u00e4rber","year":"1931","journal-title":"Naunyn-Schmiedebergs Archiv f\u00fcr experimentelle Pathologie und Pharmakologie"},{"key":"10.1016\/j.vaccine.2018.10.002_b0065","unstructured":"Recommended composition of influenza virus vaccines for use in the 2017 southern hemisphere influenza season; September 2016. Available at: <http:\/\/www.who.int\/influenza\/vaccines\/virus\/recommendations\/201609_recommendation.pdf?ua=1>."},{"key":"10.1016\/j.vaccine.2018.10.002_b0070","unstructured":"European Centre for Disease Prevention and Control. Influenza virus characterisation, summary Europe; June 2017. Available at: <https:\/\/ecdc.europa.eu\/sites\/portal\/files\/documents\/influenza-virus-characterisation-jun-2017.pdf>."},{"issue":"4","key":"10.1016\/j.vaccine.2018.10.002_b0075","doi-asserted-by":"crossref","first-page":"e61397","DOI":"10.1371\/journal.pone.0061397","article-title":"Glycosylation on hemagglutinin affects the virulence and pathogenicity of pandemic H1N1\/2009 Influenza A virus in mice","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2018.10.002_b0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jmv.1890110110","article-title":"Interference following dual inoculation with influenza A (H3N2) and (H1N1) viruses in ferrets and volunteers","volume":"11","author":"Potter","year":"1983","journal-title":"J Med Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2018.10.002_b0085","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/infdis\/173.6.1313","article-title":"Evaluation of live attenuated influenza vaccines in children 6\u201318 months of age: safety, immunogenicity, and efficacy","volume":"173","author":"Gruber","year":"1996","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2018.10.002_b0090","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/infdis\/169.5.1121","article-title":"Multidose, live attenuated, cold-recombinant, trivalent influenza vaccine in infants and young children","volume":"169","author":"Swierkosz","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.10.002_b0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/infdis\/168.1.53","article-title":"Comparison of monovalent and trivalent live attenuated influenza vaccines in young children","volume":"168","author":"Gruber","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.10.002_b0100","doi-asserted-by":"crossref","first-page":"823","DOI":"10.4161\/hv.6.10.13600","article-title":"Similar immunogenicity of the A\/H1N1 2009 pandemic influenza strain when used as a monovalent or a trivalent vaccine","volume":"6","author":"Van der Vliet","year":"2010","journal-title":"Hum Vaccin"},{"issue":"1","key":"10.1016\/j.vaccine.2018.10.002_b0105","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1471-2334-13-224","article-title":"Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomised, controlled trial in adults","volume":"13","author":"Beran","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2018.10.002_b0110","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/infdis\/jit091","article-title":"A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3\u201317 years","volume":"207","author":"Domachowske","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.10.002_b0115","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/1471-2334-13-343","article-title":"Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged \u226518 years","volume":"13","author":"Kieninger","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2018.10.002_b0120","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/infdis\/jit263","article-title":"Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children","volume":"208","author":"Langley","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.10.002_b0125","unstructured":"MedImmune LLC. A Study to Evaluate the Immunogenicity of Quadrivalent Live Attenuated Influenza Vaccine (LAIV) in Children; 2011. Available at: <https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT01091246>."},{"key":"10.1016\/j.vaccine.2018.10.002_b0130","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1586\/erv.11.73","article-title":"Protective efficacy of live-attenuated influenza vaccine (multivalent, Ann Arbor strain): a literature review addressing interference","volume":"10","author":"Bandell","year":"2011","journal-title":"Expert Rev Vacc"},{"issue":"4","key":"10.1016\/j.vaccine.2018.10.002_b0135","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/infdis\/jit207","article-title":"Evaluation of the humoral and cellular immune responses elicited by the live attenuated and inactivated influenza vaccines and their roles in heterologous protection in ferrets","volume":"208","author":"Cheng","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.10.002_b0140","doi-asserted-by":"crossref","first-page":"ofw108","DOI":"10.1093\/clinids\/3.Supplement_1.S108","article-title":"Correlates of immunity to influenza as determined by challenge of children with live, Attenuated influenza vaccine. Open Forum","volume":"3","author":"Wright","year":"2016","journal-title":"Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18313549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18313549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T13:39:51Z","timestamp":1565271591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18313549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":28,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0264410X18313549"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.10.002","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and efficacy of the monovalent, trivalent and quadrivalent intranasal live attenuated influenza vaccines containing different pdmH1N1 strains","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}